Pharmaceuticals was the organizer of the Second International Electronic Conference on Medicinal Chemistry [14] . The event gathered more than 150 authors from 22 countries (Austria, Belgium, Brazil, France, Georgia, Germany, India, Ireland, Malta, Pakistan, Portugal, Romania, Russia, Serbia, Slovakia, Spain, Switzerland, Taiwan, Turkey, Ukraine, USA, and Venezuela). It attracted 14 media partners (Analis, Bionity.com, Chemeurope.com, Cherry Biotech, Elveflow, Eurisotop, Hielscher, Latoxan, Magritek, MDPI AG, Reaction Biology Corp, Sairem, SnapDragon, and Wylton) who had the opportunity to inaugurate our new virtual exhibition hall. The best presentation, as elected by the Scientific Committee of the Conference, was the work entitled "Design, Synthesis and Biological Activity of Furoxan Derivatives against Multi-drug Resistant Tuberculosis" [15] , submitted by G. Fernandes, P. Souza, C.M. Chin, F. Pavan, and J.L. Dos Santos from the University Estadual Paulista at Araraquara, Brazil. It has been rewarded by a special travel grant offered by our journal.
Mentions should be made, in addition, that we received 83 outstanding applications for the 2016 Pharmaceuticals Travel Award for Young Investigators [16] . After a tied selection, the grant has been awarded to Dr. Zesergio Melo Jerez, of Colombia, who obtained his PhD degree in 2014 from the Universidad Nacional Autónoma de México, México City, México. The award helped him to present the oral communication entitled "Vasoinhibins Block NGF-Induced Neurite Outgrowth and Decrease Survival of PC12 Cells" at the Thirty-ninth Annual Meeting of the Japan Neuroscience Society (20-22 July, Yokohama, Japan).
Looking Forward to 2017
In 2017, we shall pursue our efforts to raise the journal to a better position still and to increase its visibility. Therefore, we can already announce that Pharmaceuticals will offer a travel grant to help support a young investigator in her/his professional career. Details of the competition can be found on our website [17] . The journal will be present at the National Meeting and Exposition of the American Chemical Society in San Francisco, USA (2-6 April, 2017) and other conferences worldwide. It will also launch the Third International Electronic Conference on Medicinal Chemistry which will take place in November on http://sciforum.net/conference/ecmc-3.
It is my pleasure to end this editorial by wishing you a healthy and prosperous new year. This is also the opportunity for me to warmly thank, for their confidence, our authors, readers, and reviewers, as well as the scientists of the editorial board, members of our teams in Basel, Barcelona, Beijing, and Wuhan, and our sponsors.
